# COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients

> **NCT03139630** · — · COMPLETED · sponsor: **Franck Boccara** · enrollment: 193 (actual)

## Conditions studied

- HIV Seropositivity
- Dyslipidemias
- PCSK9

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03139630
- **Lead sponsor:** Franck Boccara
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2024-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03139630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03139630, "COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03139630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*